Aura

Aura Announces Strong Q1 2024 Production Results, 28% Above Q1 2023 and on track to deliver its 2024 Production Guidance

Retrieved on: 
Monday, April 8, 2024
National Instrument 43-101, EPP, Gold, News, National instrument, TSX, OTCQX, Aura, Borborema, GEO, Qualified person (European Union), ROAD, Arantzazu, LTM, Rare-earth element

At constant metal prices, production was stable compared to Q4 2023 and increased by 35% compared to Q1 2023.

Key Points: 
  • At constant metal prices, production was stable compared to Q4 2023 and increased by 35% compared to Q1 2023.
  • Total production for Q1 2024 was either at or above the Company’s expectations across all its operating mines, which positions the Company to remain on track to achieve Consolidated Production Guidance of between 244,000 – 292,000 GEO for 2024.
  • At Apoena (EPP), production was 12,105 GEO, 20% lower in Q1 2024 compared to the previous quarter and 5% below Q1 2023 due to lower grade fed in the plant and mine sequencing.
  • At Almas, production in Q1 2024 reached 11,889 GEO, marking a 24% increase compared to the previous quarter.

Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, March 12, 2024
Patient, G&A, BioCryst Pharmaceuticals, Eye, Drug delivery, Clinical trial, AAO, Extension, Webcast, Pharming, CPT, Safety, Disease, SPA, American Academy of Ophthalmology, Compass, Insurance, Diabetic retinopathy, Conference call, Aura, AMD, TKI, CLS, FDA, Administration, Conference, SCS, DME, American Academy, OASIS, Injection, Research and development, Axitinib, Pharmaceutical industry

ALPHARETTA, Ga., March 12, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), today reported financial results for the fourth quarter and year ended December 31, 2023, and provided a corporate update.

Key Points: 
  • License Revenue: License and other revenue for the fourth quarter of 2023 was $6.3 million, compared to $0.3 million for the fourth quarter of 2022.
  • Research and Development (R&D) Expenses: R&D expenses for the fourth quarter of 2023 were $6.3 million, compared to $5.0 million for the fourth quarter of 2022.
  • General and Administrative (G&A) Expenses: G&A expenses for the fourth quarter of 2023 were $2.9 million, compared to $3.2 million for the fourth quarter of 2022.
  • Other Expense: Non-cash interest expense for the fourth quarter of 2023 was $2.3 million, compared to $2.0 million for the fourth quarter of 2022.

Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Retrieved on: 
Wednesday, March 27, 2024
Oncology, FDA, Health, Clinical Trials, Pharmaceutical, Biotechnology, NMIBC, Research, Melanoma, Growth, Disease, SPA, Incidence, Paratriathlon, Inflammation, Patient, Necrosis, Travel, Light, Aes, American Academy, Cancer, Șaeș, Bladder cancer, Radiation, Eye, Doctor of Philosophy, MIBC, Visual acuity, Neoplasm, ILS, Aura, Safety, Recurrence, AAO, Annual general meeting, Food, Pharmaceutical industry

Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors to preserve the function of the afflicted organ with cancer, today reported financial results for the fourth quarter and year ended December 31, 2023, and provided recent business highlights.

Key Points: 
  • Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors to preserve the function of the afflicted organ with cancer, today reported financial results for the fourth quarter and year ended December 31, 2023, and provided recent business highlights.
  • The primary endpoint is time to tumor progression when the last patient completes 15 months of follow up.
  • As of December 31, 2023, Aura had cash and cash equivalents and marketable securities totaling $226.2 million.
  • General and administrative expenses include $1.2 million and $1.1 million of stock-based compensation for the three months ended December 31, 2023 and 2022, respectively.

Enterprise Connect’s Expo Hall Features Hundreds of Innovative Products and Services to Improve Communication, Collaboration, and CX Strategies

Retrieved on: 
Monday, March 18, 2024
Hardware, IOT (Internet of Things), Social Media, Content Marketing, Technology, Public Relations, Investor Relations, Communications, Apps, Applications, Artificial Intelligence, Media, Telecommunications, Software, Networks, Internet, Mobile, Wireless, Cloud, Knowledge, Theta, Software as a service, Administrator, CX, Enterprise, SMS, Goto, Generative, AX, Pulse, Investment, Zoom, USB, Conversation, Shure, Cisco Webex, Genesys, Microsoft, BPO, TEAMS, EX, Partnership, BMA, RingCentral, AWS, Disruption, Nectar, Booth, Exhibition, RSI, PBX, System, EGain, ROI, Organization, DSP, IVR, Communication, Theatre, Chatbot, Secure, GDPR, VERSA, ASC, Cisco, Fortune 500, Aura, Microsoft Teams, Sinch, API, Expo Hall, NexGen, GoTo Resolve, LED, USB-to-serial adapter, Motus, KMS (hypertext), Culture, Logitech, AudioCodes, AVANT, CIC, Original design manufacturer, Intelligence cycle, Human, Sales

Enterprise Connect , the leading conference and exhibition for enterprise communications and customer experience, will feature hundreds of innovative products and services in the Expo Hall.

Key Points: 
  • Enterprise Connect , the leading conference and exhibition for enterprise communications and customer experience, will feature hundreds of innovative products and services in the Expo Hall.
  • “Our Expo Hall is the only place to find the enterprise communications and customer experience providers displaying their solutions in one location.
  • Attendees will have the opportunity to see the hundreds of innovative products and service available to ensure they make the best purchasing decisions to improve their communication, collaboration, and CX strategies,” said Eric Krapf, General Manager, Enterprise Connect.
  • Afiniti , Booth #1311: Afiniti is a CX AI pioneer, delivering measurable business outcomes for Fortune 500 companies since 2006.

Aura recognized on Glassdoor's "Best Places to Work 2024: Small & Medium Businesses" List

Retrieved on: 
Friday, January 26, 2024
Aura, Culture, Internet, Glassdoor, Workplace, Interface (computing), Management

BOSTON, Jan. 26, 2024 /PRNewswire/ -- Aura, the first truly intelligent safety solution for families, was recently recognized by Glassdoor as one of 2024's "Best Places to Work: Small & Medium Businesses." The annual list honors standout businesses (with fewer than 1,000 employees) for their commitment to compensation, flexibility and company culture.

Key Points: 
  • 88% of employees who reviewed Aura would recommend the company to a friend; 92% approve of Hari Ravichandran as CEO
    BOSTON, Jan. 26, 2024 /PRNewswire/ -- Aura , the first truly intelligent safety solution for families, was recently recognized by Glassdoor as one of 2024's "Best Places to Work: Small & Medium Businesses."
  • The annual list honors standout businesses (with fewer than 1,000 employees) for their commitment to compensation, flexibility and company culture.
  • The rankings of the list are determined based on employee reviews on Glassdoor.
  • "Aura's mission–to make the internet safer for all–starts with passionate, well-rounded people," said Aura Founder and CEO, Hari Ravichandran.

ASUS Republic of Gamers presents For Those Who Dare: Transcendence Virtual Launch Event at CES 2024

Retrieved on: 
Tuesday, January 9, 2024
Eclipse, Atmos, RGB, MP, OIS, Mini, Core, USB 3.0, Sensation, BUT, Asus, VESA, Those Who Dare, Ultra, Certification, OLED, Education minister, Intel, BTF, Wireless, Background, FPS, GeForce 40 series, CPU, USB 2.0, WH, GeForce, 6E, PC, Hertz, FHD, HDMI, Communication, Samsung, Dolby Vision, Microsoft, SCAR, ASUS, NOT, LAN, G14, DIY, AMD, USB, ROG, DisplayPort, Dolby Atmos, Intel Core, Carnyx, CES, Windows 11, Sync, Ecosystem, Strix, Next Unit of Computing, Freedom, G16, AI, GPU, Aura, LAS, Data-rate units, PCI Express, AMOLED, Immersion, NVIDIA, Music, Individual, ARGB, Wi-Fi, Scorpion, Conference, NUC, 720p, Temperature, IP68, SOC, Longevity, Headphones, Video game

LAS VEGAS, Jan. 8, 2024 /PRNewswire/ -- ASUS Republic of Gamers (ROG) today announced an extensive range of new and exclusive performance-focused products at it's For Those Who Dare: Transcendence virtual launch event for CES® 2024.

Key Points: 
  • Gamers can immerse themselves in the unmatched performance of the ROG Strix SCAR 18 laptop, designed for esports enthusiasts seeking maxed-out performance.
  • The new ROG Zephyrus G14 and G16 gaming laptops redefine the genre with a host of extraordinary features.
  • Both laptops are equipped with NVIDIA GeForce RTX GPUs and feature a variety of powerful ROG Intelligent Cooling solutions for optimal performance.
  • Gamers, creative professionals, or design enthusiasts can elevate their gaming reality with the Zephyrus series.

CannMart to Process First International Export of Medical-Use Cannabis to Australia

Retrieved on: 
Tuesday, December 19, 2023
Science, THC, Therapy, Aura, Growth, Drug

"We are excited to bring a diverse range of CannMart products to the Australian market in 2024,” said Tom Fay, CEO of Aura Therapeutics.

Key Points: 
  • "We are excited to bring a diverse range of CannMart products to the Australian market in 2024,” said Tom Fay, CEO of Aura Therapeutics.
  • “By fulfilling exports in an array of cannabis product categories, we will be able to expand revenue streams, while also building an international brand presence for CannMart and in-house brand Roilty concentrates.”
    The export agreement with Aura will include exclusive terms to distribute in-house brand Roilty concentrates.
  • With 4% of Australian medical cannabis users choosing THC extracts as their preferred method of consumption1, it creates an international brand-expansion opportunity and significant revenue stream with strong margin potential for CannMart in 2024.
  • As the Australian regulations and guidelines surrounding medical cannabis are like that of Canada, there will be efficacy in marketing support and brand development, leveraging proven successes from the Canadian market.

Web3 Rewards System, Aura Exchange Set to Launch $AURA Token

Retrieved on: 
Tuesday, December 12, 2023
Ethereum, Marketing, Circle, Loyalty, Multi, AURA, Uniswap, Non-fungible token, Aura, NFT, Discord, Cryptocurrency

ADELAIDE, AUSTRALIA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Aura Exchange, the first comprehensive web3 reward system, is set to launch $AURA token—an advanced marketplace coin that adds real-time value and utility to web3 projects, traders, and creators.

Key Points: 
  • ADELAIDE, AUSTRALIA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Aura Exchange, the first comprehensive web3 reward system, is set to launch $AURA token—an advanced marketplace coin that adds real-time value and utility to web3 projects, traders, and creators.
  • The $AURA token will complete the Aura Exchange rewards ecosystem.
  • $AURA will connect the Aura Exchange and the Aura+ Rewards Program, bridging the gap between cryptocurrencies and NFTs.
  • With an array of products from the Multi-chain aggregator, the Aura+ Rewards Program, and the soon-to-be-launched $AURA token, the team rewards community members like never seen before across the blockchain industry.

Aura Declares Dividend of US$0.25 per share to be Paid in December 2023

Retrieved on: 
Wednesday, November 29, 2023
Tax, Policy, OTCQX, Dividend policy, Public expenditure, ESG, Date, GEO, ROAD, Dividend, Aura, Real-time, Almas, TSX, Holding company

In accordance with the Company’s dividend policy (the “Dividend Policy”), the Dividend is in respect of and is based on Aura’s expected financial results for the six months ending on December 31, 2023.

Key Points: 
  • In accordance with the Company’s dividend policy (the “Dividend Policy”), the Dividend is in respect of and is based on Aura’s expected financial results for the six months ending on December 31, 2023.
  • The amount of the Dividend is based on the actual results for Q3 2023 and the expected results for Q4 2023, including expected production, cash costs and sustaining and exploration capex for Q4 2023.
  • The Dividend will be paid to shareholders of record on December 19, 2023, as of the close of business on December 11, 2023 (“Record Date”).
  • Holders of the Company’s Brazilian Depositary Receipts as of Record Date are expected to receive payment by December 30, 2023.

Bundle up to spend flexible spending account (FSA) dollars before the December 31 use-it-or-lose-it deadline with 10 exclusive product bundles from FSA Store

Retrieved on: 
Tuesday, December 26, 2023
Sinusitis, Allergy, Pain, Health, Commerce, Neutrogena, Pedialyte, Motion, Tylenol, Aura, Calendar, Acne, FSA, Myalgia, Massage, Travel, Ship, Pressure, Medicine cabinet, Skin, Life

DALLAS, Dec. 26, 2023 /PRNewswire-PRWeb/ -- Giving gifts to loved ones is a highlight of the holiday season, but the end of the year is also an opportunity for shoppers to give themselves the gift of better health while protecting their tax-free healthcare funds. For the millions of flexible spending account (FSA) users who face a December 31 use-it-or-use it deadline, this is the time to manage last-minute spending and avoid forfeiting an average of $300 to a missed deadline. FSA Store® makes it easy and efficient to spend FSA funds by offering exclusive product bundles that allow consumers to find and buy related products that are grouped according to popular themes or needs.

Key Points: 
  • For the millions of flexible spending account (FSA) users who face a December 31 use-it-or-use it deadline, this is the time to manage last-minute spending and avoid forfeiting an average of $300 to a missed deadline.
  • FSA Store ® makes it easy and efficient to spend FSA funds by offering exclusive product bundles that allow consumers to find and buy related products that are grouped according to popular themes or needs.
  • Our exclusive product bundles are the perfect way to spend funds – whether you have $20 or $200 in your FSA – on items that you will use every day.
  • To learn more about the FSA deadline and how to spend funds before Dec. 31, visit FSAstore.com and the FSA Learning Center .